Search Results 371-380 of 18837 for alzheimers
These Alzheimer's disease medicines increase levels of chemical messengers in the brain, known as neurotransmitters. These chemical messengers are believed to ...
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia · More about research at Mayo Clinic · Mayo Clinic Footer · Mayo Clinic ...
A multidisciplinary faculty guides research in the Mayo Clinic Alzheimer's Disease Research Center.
The goal is to identify and characterize novel genes, transcripts and genetic risk variants for late-onset Alzheimer's disease. Gene Expression Studies in ...
The results suggest varying brain activity may reduce the risk of Alzheimer's disease. The study, “Non-stationarity in the “Resting Brain's” Modular ...
Faculty and staff of Dr. Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes Lab at Mayo Clinic's campus in Florida.
Alzheimer's disease is one of the most feared of all illnesses. Besides ... Ann Miller was diagnosed with. Alzheimer's disease three years ago. Hoping ...
Dementia is an umbrella term for a group of symptoms affecting memory, thinking and social abilities. It's not one disease. And Alzheimer's disease is the most ...
I have been studying molecular pathogenesis of Alzheimer's disease since 1995, and I also have been testing viral gene therapy since 2005. Why and how did you ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.